Most Recent
Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.
The makers of Grand Theft Auto have largely succeeded in a copyright case against the developer behind the "Infamous Mod" -- a hack that alters the capabilities of players in the online version of the top-selling game.
The High Court has rejected Aristocrat's request that it rule again on the patentability of its popular Lightning Link game, after a differently comprised court was split on when computer-implemented inventions can be patented.
Defunct Westpac mortgage broker RAMS has reached a settlement in a trade mark stoush with fund manager Real Asset Management.
Despite failing a second time to make the deadline, Advanta Seeds has won an extension to pay a renewal fee for its patent for a lucrative hybrid canola plant cell.
Online fashion retailer FWRD has lost its challenge to registration of the 'FFWD' trade mark by data processing software company Corezero.
A patent examiner who questioned IP Australia's examination processes has lost his appeal of a Fair Work Commission decision that found he was not forced to resign from his job.
Swiss aircraft manufacturer Pilatus has won discovery to pursue a possible copyright claim stemming from a Royal Australian Air Force flight simulator contract.
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.
Radio manufacturer Hytera wants the High Court to hear its appeal of a finding that it misappropriated Motorola's source code in a case of "substantial industrial theft”.